Daily adaptive radiotherapy aims to cut side effects in pelvic cancers
NCT ID NCT07516210
First seen Apr 11, 2026 · Last updated Apr 30, 2026 · Updated 2 times
Summary
This study tests a new way to give radiation for prostate, endometrial, cervical, and rectal cancers. Instead of standard daily doses, it uses daily scans to adjust the radiation beam precisely to the tumor, allowing fewer but stronger treatments. The goal is to see if this approach causes fewer side effects while still controlling the cancer. About 264 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, H2L 0H5, Canada
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.